TRAIL-R1 (DR4) was expressed in all tested DLBCL cell lines, while TRAIL-R2 (DR5) was highly expressed in ABC-DLBCL and in 3/7 tested GC-DLBCL cell lines (Figure 1). This evidence concerns the gene TNFRSF10A and diffuse large B-cell lymphoma.